Coherus BioSciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $70,774 | $64,979 | $77,063 | $91,524 |
Gross Profit | 50,033 | 35,424 | 40,970 | 5,894 |
EBITDA | -3,840 | -6,400 | -30,418 | -67,971 |
EBIT | -5,389 | -7,587 | -31,925 | -69,034 |
Net Income | -10,751 | -12,921 | 102,875 | -79,653 |
Net Change In Cash | 70,774 | 64,979 | 77,063 | 91,524 |
Free Cash Flow | -62,016 | 59,734 | -46,766 | -12,971 |
Cash | 97,690 | 159,240 | 259,774 | 102,891 |
Basic Shares | 115,210 | 114,819 | 125,529 | 111,492 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $257,244 | $211,042 | $326,551 | $475,824 |
Gross Profit | 94,461 | 140,959 | 268,960 | 438,157 |
EBITDA | -193,939 | -255,581 | -260,687 | 161,842 |
EBIT | -197,730 | -259,280 | -266,348 | 156,873 |
Net Income | -237,892 | -326,628 | -306,322 | 132,244 |
Net Change In Cash | 257,244 | 211,042 | 326,551 | 475,824 |
Cost of Revenue | -353,648 | -123,963 | 363,690 | |
Free Cash Flow | -175,170 | -243,163 | -38,721 | 147,089 |
Cash | 102,891 | 63,547 | 417,195 | 541,158 |
Basic Shares | 94,162 | 77,630 | 75,449 | 83,491 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.62 |
